Conray 600 mg/mL

Conray 600 mg/mL is an injectable solution containing iothalamate meglumine, used for diagnostic imaging procedures. This contrast agent aids in enhancing visibility during X-ray and fluoroscopy.

Conray 600 mg/mL is primarily used as a contrast medium for diagnostic imaging. It is administered intravenously to improve the clarity of structures within the body during X-ray and fluoroscopy procedures. This helps healthcare professionals to better visualize and assess internal organs and tissues. The primary use of iothalamate meglumine is to enhance the quality of diagnostic images, making it easier to identify abnormalities or areas of concern.

Common effects of Conray 600 mg/mL may include a warm sensation or a metallic taste in the mouth following administration. Some individuals might experience mild nausea or dizziness. These effects are generally temporary and subside quickly. Severe reactions are rare but can occur, and immediate medical attention should be sought if any unusual symptoms arise.

Conray 600 mg/mL should be used with caution in individuals with a history of allergic reactions to contrast media. It is important to inform healthcare providers about any known allergies or medical conditions before administration. Pregnant women and individuals with kidney problems should discuss the potential risks and benefits with their healthcare provider.

Conray 600 mg/mL may interact with certain medications, including those that affect kidney function. It is advisable to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and other substances that affect kidney function should be avoided before and after administration.